← Eichor
Condition: Areata Alopecia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Areata Alopecia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Determinants of Chronic Inflammatory Skin Disease Trajectories
Phase N/A · 1 location(s) · University Hospital Schleswig-Holstein · NCT05928169Intralesional Cyclosporine for Alopecia Areata
EARLY_Phase 1 · 1 location(s) · University of California, Davis · NCT07029204Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata
Phase 3 · 18 location(s) · Sun Pharma Japan Limited · NCT07617597A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Phase 1 · 6 location(s) · Forte Biosciences, Inc. · NCT07205159Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Phase 3 · 64 location(s) · Sun Pharmaceutical Industries, Inc. · NCT07133308HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
Phase 1 · 2 location(s) · HCW Biologics · NCT07049328Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areat
NA · 1 location(s) · Universidad Autonoma de Nuevo Leon · NCT06564805Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers A
Phase 1 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07554222Regeneron AA Multicenter (Dupilumab)
Phase 2 · 3 location(s) · Emma Guttman · NCT05551793Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata
Phase 2 · 2 location(s) · NEXTGEN Bioscience · NCT06104839CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
Phase N/A · 1 location(s) · CorEvitas · NCT05745389PALLAS Laser for Skin Diseases
NA · 1 location(s) · Szeged University · NCT07250997A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Phase 3 · 41 location(s) · Pfizer · NCT07029828A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo
Phase N/A · 116 location(s) · AbbVie · NCT07136467Dupilumab in the Treatment of Pediatric Alopecia Areata
Phase 2 · 5 location(s) · Icahn School of Medicine at Mount Sinai · NCT05866562Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
Phase 2 · 1 location(s) · University of Minnesota · NCT06747611A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
Phase N/A · 1 location(s) · Pfizer · NCT07152119Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study
Phase 4 · 1 location(s) · Erasmus Medical Center · NCT07381556A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan W
Phase 3 · 15 location(s) · AbbVie · NCT07023302Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06573593Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07242638Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidia
Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05398809CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
Phase N/A · 1 location(s) · CorEvitas · NCT06562270Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of
NA · 1 location(s) · Zagazig University · NCT06327581Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06801821A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Sever
Phase 3 · 282 location(s) · AbbVie · NCT06012240Systemic Treatments for Alopecia Areata Registry
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT06283316A Study of LAD603 in Adults With Alopecia Areata
Phase 2 · 1 location(s) · Almirall, S.A. · NCT07311564A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Phase 3 · 127 location(s) · Eli Lilly and Company · NCT05723198A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Phase 2 · 30 location(s) · Eli Lilly and Company · NCT07533006
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.